IP Verse

Celator Pharmaceuticals, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Celator Pharmaceuticals, Inc. opposed by its competitors

Patent:
EP3300601
Grant Date:
Jan 12, 2022
Title:
Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders
Oppositions:
3
Patent:
EP2768484
Grant Date:
Jul 24, 2019
Title:
Lyophilized Liposomes
Oppositions:
2
Patent:
EP2120568
Grant Date:
Nov 15, 2017
Title:
Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders
Oppositions:
2

Competitors of Celator Pharmaceuticals, Inc.

SANDOZ AG

D YOUNG & CO LLP

GENERICS [UK] LIMITED

Want to track Celator Pharmaceuticals, Inc.?

Feel free to send us a message here and we will get back to you